Institutional investors hold a majority ownership of TEVA through the 60.67% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Generic industry. Last, during the quarter ended December 2015, these large investors purchased a net $77.5 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
NORDEA INVESTMENT MANAGEMENT AB ... Bought 5.7 Million shares of Teva Pharmaceutical